Form D · Pharmaceuticals
Biostar Pharmaceuticals, Inc.
Xianyang, Shaanxi, F4 · CIK 0001418133
Offering snapshot reported Nov 25, 2009 · SEC filing
- Reported sold
- $2.12M Offering amount: $2.12M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 18, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 25, 2009 | Initial | $2,120,000 | No comparison | 13 | SEC filing |
| Nov 13, 2009 | Initial | $3,605,000 | No comparison | 14 | SEC filing |
| Nov 27, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-111544
Source: Form D, filed Nov 25, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shuang Gong | Executive |
| Qinghua Liu | Director |
| Xifeng Nie | Director |
| Michael Segal | Director |
| Ronghua Wang | Director, Executive |
| Haipeng Wu | Director |
| Amei Zhang | Executive |
| Elaine Zhao | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
No. 588 Shiji Xi Road
Xianyang, Shaanxi, F4, 712046
Xianyang, Shaanxi, F4, 712046